Russo v. Walgreen Co.

CourtDistrict Court, N.D. Illinois
DecidedAugust 7, 2025
Docket1:17-cv-02246
StatusUnknown

This text of Russo v. Walgreen Co. (Russo v. Walgreen Co.) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Russo v. Walgreen Co., (N.D. Ill. 2025).

Opinion

UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

CYNTHIA RUSSO, LISA BULLARD, ) RICARDO GONZALES, INTERNATIONAL ) BROTHERHOOD OF ELECTRICAL ) WORKERS LOCAL 38 HEALTH AND ) WELFARE FUND, INTERNATIONAL ) UNION OF OPERATING ENGINEERS ) LOCAL 295-295C WELFARE FUND, ) AND STEAMFITTERS FUND LOCAL 439, ) on Behalf of Themselves and All Others ) No. 1:17-CV-02246 Similarly Situated, ) ) Plaintiffs, ) Judge Edmond E. Chang ) v. ) ) WALGREEN CO., ) ) Defendant. )

MEMORANDUM OPINION AND ORDER Cynthia Russo, Lisa Bullard, and Ricardo Gonzales, along with the Interna- tional Brotherhood of Electrical Workers Local 38 Health and Welfare Fund, the In- ternational Union of Operating Engineers Local 295-295c Welfare Fund, and the Steamfitters Fund Local 439 (collectively, “the Plaintiffs”) filed this class action law- suit against Walgreens. The Plaintiffs allege that Walgreens engaged in an improper pricing scheme—via Walgreens’ Prescription Savings Club—that artificially inflated Walgreens’ “usual and customary” prices and resulted in the Plaintiffs’ overpayment of generic prescription drugs. See generally R. 477, Fourth Am. Compl.1 Eventually,

1Citations to the record are “R.” followed by the docket entry number and, if needed, a page or paragraph number. The Court has jurisdiction over this matter under the Class Action Fairness Act, 28 U.S.C. § 1332(d)(2). The amount-in-controversy requirement is met: the Plaintiffs and Walgreens entered into a class action Settlement Agreement in which Walgreens agreed to pay the Settlement Class $100 million and end its Pre- scription Savings Club. See generally R. 683-1, Guglielmo Decl. Exh. 1, Settlement

Agreement. This Court granted preliminary approval of the Settlement Agreement in November 2024. See generally R. 689, Prelim. Approval Ord. Now, the Plaintiffs move to invalidate certain requests to opt out of the Settle- ment Agreement submitted by various Blue Cross Blue Shield entities (for conven- ience’s sake, the Blues) and Health Care Service Corporation (which goes by HCSC) on behalf of over 24,000 would-be Settlement Class Members. R. 723, Pls.’ Mot. The Plaintiffs also move to overrule the insurance companies’ objections to the opt-out

procedure required by the preliminary approval Order. Id. For the reasons discussed in this Opinion, the Plaintiffs’ motion is granted in full: the exclusion requests are denied. I. Background Walgreens is a nationwide retail pharmacy with headquarters in Deerfield, Il- linois. Fourth Am. Compl. ¶¶ 7, 41. The Plaintiffs are comprised of: (1) individuals

that purchased the generic versions of prescription medications at Walgreens through insurance plans and (2) employee-benefit plans and non-profit trusts that

the Plaintiff class seeks damages for hundreds of thousands of class members and the parties’ Settlement Agreement calls for payment of $100 million to satisfy those damages. Fourth Am. Compl. ¶ 45; R. 683-1, Guglielmo Decl. Exh. 1, Settlement Agreement at 14. Minimal diversity is also met because Walgreens is a citizen of Illinois, Fourth Am. Compl. ¶ 41, and at least one Plaintiff class member is a citizen of a different state. See id. ¶ 23. 2 provide healthcare benefits to individuals covered by certain collective-bargaining agreements. Id. ¶¶ 17, 20, 23, 26–27, 30–31, 34–35. The allegations in this case are based on Walgreens’ “Prescription Savings Club,” which allows customers that pay

directly for prescriptions (that is, without using health insurance) to purchase generic prescription drugs at specified prices. Id. ¶¶ 4, 8–9, 11. According to the Plaintiffs, Walgreens charged them much more for the same prescription drugs than it charged the Prescription Savings Club members, effectively maintaining a dual-pricing scheme. Id. at 4, 6. The Plaintiffs alleged that this dual-pricing scheme allowed Walgreens to charge them a higher price than the “usual and customary” price, which is the price that a pharmacy charges the direct-paying public. See id. ¶¶ 5, 58. These

alleged overpayments form the basis for the Plaintiffs’ claims of significant financial damages spanning from 2007 to the present. See id. ¶ 13. The Plaintiffs sought certification of a nationwide class under Civil Rule 23(a) and (b)(3). Id. ¶¶ 91–99. The parties reached a Settlement Agreement in October 2024; in November, the Court granted preliminary certification of the following Set- tlement Class:

All individuals or entities in the United States and its territories who paid, in whole or in part, at any point in time from January 1, 2007 through [date of preliminary approval of the Settlement or December 31, 2024, whichever comes first] (“Settlement Class Period”), for one or more prescription drugs from Walgreens, where prescription insurance benefits were used in filling the prescription(s).

Prelim. Approval Ord. at 1, 3. But there is a carve-out from the class definition: it excludes “all individuals and entities … that have sued … Walgreens relating to its 3 determination of usual and customary prices in connection with the Prescription Sav- ings Club.” Id. at 3. In the preliminary-approval order, the Court directed the settle- ment administrator to implement a notice plan consisting of (1) direct email notice

for potential Settlement Class Members containing summary notice; (2) supple- mental paid-media notice via social media and digital advertising to targeted de- mographics; (3) postcard and email notice to third-party payor entities including health insurers and self-insured entities; and (4) press releases. See R. 684, Miller Decl. on Class Notice ¶¶ 10–20 (detailing the notice plan); Prelim. Approval Ord. ¶¶ 10–11 (approving the notice plan detailed in the Miller Declaration on Class No- tice). The notice deadline passed in January 2025. Prelim. Approval Ord. ¶ 30.

The preliminary-approval order also set requirements for requests by class members to exclude themselves from the settlement. In particular, the order required “individual” requests, instructing that “request[s] for exclusion must be submitted by each Settlement Class Member on an individual basis,” and that “group or class-wide exclusions shall not be permitted.” Id. ¶ 14 (emphasis added). Settlement Class Mem- bers that wished to opt-out were directed to send written requests to the Settlement

Administrator; these requests had to “be signed by the person authorized to do so.” Id. ¶ 15. Among other things, the Order also required that requests include certain identifying information, such as the member’s full name, telephone number, identifi- cation number, and information establishing class membership. Id. ¶ 15(a). Entities were specifically instructed to provide “a signature from the authorized representa- tive of the entity.” Id. ¶ 15(a)(ii). Finally, the Order advised that “any request for 4 exclusion by a purported authorized agent or representative of a Class Member must include proof of the representative’s legal authority and authorization to act and re- quest exclusion on behalf of each Class Member for which the representative requests

exclusion.” Id. ¶ 14. The deadline to submit exclusion requests was in March 2025. Prelim. Approval Ord. ¶ 30. To understand the current dispute, it is important to know that the Settlement Class definition includes third-party payors, that is, commercial entities that utilize self-funded (rather than fully funded) health-insurance plans for their employees. R. 755, Insurers’ Resp. at 4. Those commercial entities (referred to by the parties as “Administrative Services Only clients,” or “ASO clients”) contract with health-insur-

ance companies; the insurers pay pharmacy claims on behalf of the ASO clients and then seek reimbursement later.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Russo v. Walgreen Co., Counsel Stack Legal Research, https://law.counselstack.com/opinion/russo-v-walgreen-co-ilnd-2025.